SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kopran - Quaterly Results

15 May 2025 Evaluate
The sales slipped to Rs. 759.35 millions for the March 2025 quarter as against Rs. 906.23 millions during the year-ago period.A big decline of -43.84% was reported for the quarter ended March 2025 to Rs. 85.98  millions from Rs. 153.09 millions of corresponding previous quarter.The company reported a degrowth in operating Profit to 142.04 millions from 234.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 759.35 906.23 -16.21 2710.10 3374.56 -19.69 2710.10 3374.56 -19.69
Other Income 19.18 81.49 -76.46 59.04 167.11 -64.67 59.04 167.11 -64.67
PBIDT 142.04 234.90 -39.53 445.60 536.37 -16.92 445.60 536.37 -16.92
Interest 12.58 17.79 -29.29 37.66 45.01 -16.33 37.66 45.01 -16.33
PBDT 129.46 217.11 -40.37 407.94 491.36 -16.98 407.94 491.36 -16.98
Depreciation 12.39 11.62 6.63 49.99 46.20 8.20 49.99 46.20 8.20
PBT 117.07 205.49 -43.03 357.95 445.16 -19.59 357.95 445.16 -19.59
TAX 31.09 52.40 -40.67 89.38 98.79 -9.53 89.38 98.79 -9.53
Deferred Tax 3.74 0.10 3640.00 3.06 -2.03 -250.74 3.06 -2.03 -250.74
PAT 85.98 153.09 -43.84 268.57 346.37 -22.46 268.57 346.37 -22.46
Equity 482.86 482.11 0.16 482.86 482.11 0.16 482.86 482.11 0.16
PBIDTM(%) 18.71 25.92 -27.84 16.44 15.89 3.45 16.44 15.89 3.45

Kopran Share Price

157.10 0.90 (0.58%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×